GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kalaris Therapeutics KLRS · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.30

-4.96%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Kalaris Therapeutics

Our reporting

Next results

11 Nov 2026

Due on 11 Nov 2026. Analysts expect earnings of -0.52 a share.

Past results

Reported against what analysts expected

11 Aug 202612 May 202617 Mar 202612 Nov 202513 Aug 20257 Mar 2025
Earnings per share-0.48-0.46-0.44-0.64-0.61-3.64
Forecast-0.49-0.52-0.56-0.66-0.51-2.76

Key events

  1. 19 Mar 20251-to-1 reverse split
  2. 16 Jan 202523-to-1 reverse split
  3. 30 Jul 2020Listed

Kalaris Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.